Decreasing sympathetic activity
|
Centrally acting –clonidine –methyldopa –moxonidine –reserpine –barbiturates –anaesthetics
|
Peripherally acting –sympathetic nerve endings (guanethidine, bethanidine) –α adrenoceptor blockade (phenoxybenzamine) –β adrenoceptor blockade (propranolol)
|
Increasing sympathetic activity
-
–amphetamines
-
–releasing noradrenaline (tyramine)
-
–uptake blockers (imipramine)
-
–monoamine oxidase inhibitors (tranylcypromine)
-
–β adrenoceptor stimulants (isoprenaline)
|
Decreasing parasympathetic activity
-
–antidepressants (imipramine)
-
–tranquillisers (phenothiazines)
-
–antidysrhythmics (disopyramide)
-
–anticholinergics (atropine, probanthine, benztropine)
-
–toxins (botulinum)
|
Increasing parasympathetic activity
-
–cholinomimetics (carbachol, bethanechol, pilocarpine, mushroom poisoning)
-
–anticholinesterases
-
–reversible carbamate inhibitors (pyridostigmine, neostigmine)
-
–organophosphorous inhibitors (parathion, sarin)
|
Miscellaneous
-
–alcohol, thiamine (vitamin B1) deficiency
-
–vincristine, perhexiline maleate
-
–thallium, arsenic, mercury
-
–mercury poisoning (pink disease)
-
–ciguatera toxicity
-
–jellyfish and marine animal venoms
-
–first dose of certain drugs (prazosin, captopril)
-
–withdrawal of chronically used drugs (clonidine, opiates, alcohol)
|